Article
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Season 2, Episode 21: A Century of X-Rays with Margaret Yu
In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care.
Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new radioisotope-linked therapies to transform precision oncology.
She also shares deeply personal stories from her medical training, lessons from mentorship, and how being a “language brain in a science-driven world” shapes her communication and leadership approach. In the closing moments, Dr. Yu offers invaluable leadership advice on resilience, growth, and embracing challenges for anyone navigating their first leadership role in Pharma or biotech.
Whether you’re a Pharma executive, biotech innovator, or medical professional, this conversation delivers both inspiration and insight into the future of cancer treatment and scientific leadership.
Related Topics
You May Also Like
Massimo Di Maio, Francesco Perrone, Pierfranco Conte
Article
E.M. Ray, L.A. Carey, K.E. Reeder-Hayes
Leveraging existing data to contextualize phase II clinical trial findings in oncology
Podcast
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal